ORGANON PHARMA PTY LTD

NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system (381186)

29 March 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system.

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

ORGANON PHARMA PTY LTD

NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system (381186)

IMPLANON NXT etonogestrel 68mg subcutaneous implant blister pack Cancelled under Section 30(1)(c) of the Act

Product regulation

Safety and shortages

Resources and guidance

Business services

ORGANON PHARMA PTY LTD

Type

Date

NUVARING etonogestrel 11.7 mg and ethinylestradiol 2.7 mg vaginal drug delivery system (381186)

IMPLANON NXT etonogestrel 68mg subcutaneous implant blister pack Cancelled under Section 30(1)(c) of the Act